◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › CBT

Cabot Corporation (CBT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · SPECIALTY CHEMICALS · DATA UPDATED 2026-08-22

Cabot Corporation (CBT) operates in the SPECIALTY CHEMICALS industry and is headquartered in Boston, United States with about 4,064 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-09-30, CBT reported $3.7B in revenue and $331M in net income.

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals.

Interactive charts & full statements → Open the CBT valuation workbench →

CBT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Revenue	$3.6B	$3.7B	$4.0B	$3.9B	$4.3B	$3.4B	$2.6B	$3.3B	$3.2B	$2.7B	$2.4B	$2.9B	$3.6B	$3.5B	$3.3B	$3.1B	$2.9B	$2.2B	$3.2B	$2.6B	$2.5B
Gross Profit	$832M	$940M	$960M	$839M	$885M	$799M	$500M	$685M	$781M	$652M	$578M	$587M	$721M	$636M	$649M	$558M	$564M	$227M	$485M	$505M	$419M
Gross Margin %	22.9%	25.3%	24.0%	21.3%	20.5%	23.4%	19.1%	20.5%	24.1%	24.0%	24.0%	20.4%	19.8%	18.4%	19.7%	18.0%	19.5%	10.1%	15.2%	19.3%	16.5%
Operating Income (EBIT)	$501M	$621M	$614M	$526M	$389M	$454M	$21M	$306M	$156M	$336M	$250M	$38M	$335M	$263M	$290M	$243M	$248M	($54M)	$164M	$187M	$126M
Operating Margin %	13.8%	16.7%	15.4%	13.4%	9.0%	13.3%	0.8%	9.2%	4.8%	12.4%	10.4%	1.3%	9.2%	7.6%	8.8%	7.8%	8.6%	-2.4%	5.1%	7.1%	5.0%
Net Income	$190M	$331M	$380M	$445M	$209M	$250M	($238M)	$157M	($113M)	$241M	$149M	($331M)	$201M	$155M	$389M	$235M	$154M	($77M)	$86M	$129M	$88M
Net Margin %	5.2%	8.9%	9.5%	11.3%	4.8%	7.3%	-9.1%	4.7%	-3.5%	8.9%	6.2%	-11.5%	5.5%	4.5%	11.8%	7.6%	5.3%	-3.4%	2.7%	4.9%	3.5%
EBITDA	$690M	$794M	$761M	$685M	$537M	$615M	$178M	$462M	$323M	$499M	$455M	($141M)	$565M	$493M	$447M	$381M	$391M	$97M	$313M	$336M	$257M
Earnings Per Share (EPS)	$3.60	$6.11	$6.82	$7.88	$3.67	$4.40	$-4.20	$2.67	$-1.83	$3.84	$2.37	$-5.22	$3.09	$2.40	$6.06	$3.59	$2.36	$-1.22	$1.34	$1.90	$1.29
Shares Outstanding (M)	52M	54M	56M	56M	57M	57M	57M	59M	62M	63M	63M	63M	65M	64M	64M	65M	65M	63M	64M	68M	68M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CBT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$982M	$904M	$849M	$899M	$923M	$936M	$955M	$1.0B
Gross Profit	$184M	$217M	$211M	$220M	$244M	$241M	$235M	$240M
Gross Margin %	18.7%	24.0%	24.9%	24.5%	26.4%	25.8%	24.6%	24.0%
Operating Income (EBIT)	$98M	$137M	$129M	$137M	$167M	$162M	$155M	$150M
Operating Margin %	10.0%	15.2%	15.2%	15.2%	18.1%	17.3%	16.2%	15.0%
Net Income	$6M	$68M	$73M	$43M	$101M	$94M	$93M	$137M
Net Margin %	0.6%	7.5%	8.6%	4.8%	10.9%	10.0%	9.7%	13.7%
EBITDA	$148M	$190M	$177M	$175M	$213M	$208M	$199M	$191M
Earnings Per Share (EPS)	$0.12	$1.30	$1.38	$0.81	$1.88	$1.73	$1.69	$2.48
Shares Outstanding (M)	52M	52M	53M	53M	54M	54M	55M	55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CBT Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Cash from Operations (CFO)	$497M	$665M	$692M	$595M	$100M	$257M	$377M	$361M	$299M	$340M	$386M	$489M	$305M	$419M	$415M	$195M	$249M	$399M	$124M	$309M	$252M
Capital Expenditures (CapEx)	$216M	$274M	$241M	$244M	$211M	$195M	$200M	$224M	$229M	$147M	$112M	$141M	$171M	$264M	$281M	$230M	$108M	$106M	$199M	$141M	$188M
Free Cash Flow (FCF)	$281M	$391M	$451M	$351M	($111M)	$62M	$177M	$137M	$70M	$193M	$274M	$348M	$134M	$155M	$134M	($35M)	$141M	$293M	($75M)	$168M	$64M
FCF Margin %	7.7%	10.5%	11.3%	8.9%	-2.6%	1.8%	6.8%	4.1%	2.2%	7.1%	11.4%	12.1%	3.7%	4.5%	4.1%	-1.1%	4.9%	13.1%	-2.4%	6.4%	2.5%
Dividends Paid	$97M	$96M	$93M	$88M	$84M	$80M	$80M	$80M	$80M	$77M	$65M	$56M	$54M	$51M	$49M	$47M	$53M	$57M	$47M	$48M	$43M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CBT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$75M	$77M	$126M	$219M	$249M	$73M	$124M	$204M
Capital Expenditures (CapEx)	$38M	$45M	$69M	$64M	$34M	$99M	$77M	$92M
Free Cash Flow (FCF)	$37M	$32M	$57M	$155M	$215M	($26M)	$47M	$112M
FCF Margin %	3.8%	3.5%	6.7%	17.2%	23.3%	-2.8%	4.9%	11.2%
Dividends Paid	$24M	$24M	$24M	$25M	$24M	$23M	$24M	$24M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CBT Balance Sheet History

Balance sheet	2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Assets	$4.0B	$3.8B	$3.7B	$3.6B	$3.5B	$3.3B	$2.8B	$3.0B	$3.2B	$3.3B	$3.2B	$3.1B	$4.1B	$4.3B	$4.3B	$3.1B	$2.9B	$2.7B	$2.9B	$2.6B	$2.5B
Cash & Cash Equivalents	$250M	$258M	$223M	$238M	$206M	$168M	$151M	$169M	$175M	$280M	$200M	$77M	$66M	$95M	$120M	$286M	$388M	$304M	$129M	$154M	$189M
Total Liabilities	$2.2B	$2.1B	$2.1B	$2.2B	$2.5B	$2.2B	$2.0B	$1.9B	$2.0B	$1.7B	$1.8B	$1.7B	$2.0B	$2.2B	$2.4B	$1.5B	$1.5B	$1.4B	$1.5B	$1.4B	$1.3B
Total Debt (Short + Long-Term)	$1.3B	$1.1B	$1.2B	$1.3B	$1.4B	$1.2B	$1.1B	$1.1B	$1.0B	$924M	$926M	$1.0B	$1.1B	$1.3B	$1.4B	$699M	$652M	$657M	$716M	$585M	$551M
Total Shareholders' Equity	$1.6B	$1.6B	$1.4B	$1.3B	$898M	$947M	$691M	$998M	$1.2B	$1.5B	$1.3B	$1.3B	$1.9B	$2.0B	$1.8B	$1.5B	$1.3B	$1.1B	$1.2B	$1.2B	$1.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CBT viewer.

Other Companies in SPECIALTY CHEMICALS

SXT · Sensient Technologies Corporation — $6 billion
BCPC · Balchem Corporation — $5 billion
PRM · Perimeter Solutions SA — $5 billion
CLMT · Calumet Specialty Products Partners — $5 billion
AVNT · Avient Corp — $4 billion
ASH · Ashland Global Holdings Inc — $3 billion
FUL · H B Fuller Company — $3 billion
KWR · Quaker Chemical Corporation — $3 billion

← CBSM All “C” companies CBTA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.